United States (US) Immunology Market (2025-2031) Outlook | Size, Analysis, Revenue, Companies, Trends, Growth, Forecast, Value, Industry, Share

Market Forecast By Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), Others), By Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And Competitive Landscape
Product Code: ETC328861 Publication Date: Aug 2022 Updated Date: Jul 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Sumit Sagar No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

United States (US) Immunology Market Synopsis

The United States Immunology Market is a dynamic and rapidly evolving sector within the healthcare industry. With a strong emphasis on research and development, the market is characterized by a wide range of innovative therapies for various autoimmune diseases, such as rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Key players in the market include pharmaceutical companies like AbbVie, Johnson & Johnson, and Amgen, who are continuously investing in new treatments and technologies to address the growing demand for immunology therapies. The market is also witnessing a shift towards personalized medicine, with a focus on precision therapies tailored to individual patient needs. Regulatory approvals, market access, and pricing strategies are critical factors influencing market growth. Overall, the US Immunology Market presents significant opportunities for stakeholders across the value chain, driving advancements in patient care and treatment outcomes.

United States (US) Immunology Market Trends

The US Immunology Market is experiencing a surge in demand for biologic therapies, particularly for autoimmune diseases like rheumatoid arthritis, psoriasis, and inflammatory bowel disease. Key trends include the development of novel biologics with improved efficacy and safety profiles, increased adoption of biosimilars leading to cost savings, and a growing emphasis on personalized medicine through biomarker testing. Additionally, there is a shift towards patient-centric care, with a focus on improving treatment outcomes and quality of life for individuals with chronic immunological conditions. The market is also witnessing advancements in immunotherapy for cancer treatment, with innovative approaches such as checkpoint inhibitors and CAR-T cell therapy gaining traction. Overall, the US Immunology Market is evolving rapidly to meet the complex healthcare needs of patients while driving innovation in treatment options.

United States (US) Immunology Market Challenges

The US Immunology Market faces several challenges, including increasing competition from biosimilar products, pricing pressures, and regulatory uncertainties. The rise of biosimilars has led to intensified competition in the market, impacting the sales of established immunology drugs. Pricing pressures from payers and the need to demonstrate cost-effectiveness are also significant challenges for companies operating in this space. Moreover, regulatory uncertainties, such as changing reimbursement policies and regulatory requirements, create additional complexities for market players. Adapting to these challenges requires companies to innovate in their product offerings, demonstrate value to stakeholders, and navigate the evolving regulatory landscape effectively to maintain competitiveness in the US Immunology Market.

United States (US) Immunology Market Investment Opportunities

The US Immunology Market offers several promising investment opportunities, driven by factors such as increasing prevalence of autoimmune diseases, advancements in biologic therapies, and growing demand for personalized medicine. Biopharmaceutical companies focused on developing innovative immunology treatments, particularly in areas such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis, present attractive investment prospects. Additionally, companies specializing in immunotherapy, including checkpoint inhibitors and CAR-T cell therapies for cancer treatment, are experiencing significant growth and investment interest. Furthermore, the expanding market for diagnostic tools and technologies to support immunology research and treatment is creating opportunities for investment in companies developing cutting-edge diagnostic tests and precision medicine solutions tailored to individual immune system profiles. Overall, the US Immunology Market holds promise for investors seeking exposure to the rapidly evolving field of immunology therapeutics and diagnostics.

Jordan Agar Market Government Policies

The US government plays a significant role in shaping the Immunology Market through various policies and regulations. The US Food and Drug Administration (FDA) regulates the approval and marketing of immunology drugs, ensuring their safety and efficacy. The government also provides funding for research and development in the field of immunology through agencies like the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC). Additionally, policies related to healthcare reimbursement and insurance coverage impact the accessibility of immunology treatments for patients. Overall, government policies in the US Immunology Market focus on promoting innovation, ensuring patient safety, and improving access to immunology therapies.

United States (US) Immunology Market Future Outlook

The future outlook for the United States Immunology Market is promising, driven by factors such as the increasing prevalence of autoimmune diseases, advancements in immunotherapy and biologic treatments, and growing investment in research and development. The market is expected to see continued growth as new therapies are developed and personalized medicine becomes more prevalent. Additionally, the rising awareness of the importance of immune health and the potential for immunology to revolutionize treatment across various disease areas will further drive market expansion. However, challenges such as high treatment costs and regulatory hurdles may impact the market`s growth to some extent. Overall, the US Immunology Market is poised for expansion and innovation in the coming years.

Key Highlights of the Report:

  • United States (US) Immunology Market Outlook
  • Market Size of United States (US) Immunology Market, 2024
  • Forecast of United States (US) Immunology Market, 2031
  • Historical Data and Forecast of United States (US) Immunology Revenues & Volume for the Period 2021 - 2031
  • United States (US) Immunology Market Trend Evolution
  • United States (US) Immunology Market Drivers and Challenges
  • United States (US) Immunology Price Trends
  • United States (US) Immunology Porter's Five Forces
  • United States (US) Immunology Industry Life Cycle
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Drug Class for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Monoclonal Antibody (mAb) for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Fusion Proteins for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Immunosuppressants for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Polyclonal Antibody (pAb) for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Disease Indication for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Rheumatoid Arthritis for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Psoriatic Arthritis for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Plaque Psoriasis for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Ankylosing Spondylitis for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Inflammatory Bowel Disease for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Prophylaxis of Organ Rejection for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Others for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Distribution Channel for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Hospital Pharmacies for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Retail Pharmacies for the Period 2021 - 2031
  • Historical Data and Forecast of United States (US) Immunology Market Revenues & Volume By Online Pharmacies for the Period 2021 - 2031
  • United States (US) Immunology Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Disease Indication
  • Market Opportunity Assessment By Distribution Channel
  • United States (US) Immunology Top Companies Market Share
  • United States (US) Immunology Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Immunology Company Profiles
  • United States (US) Immunology Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Immunology Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Immunology Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Immunology Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Immunology Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Immunology Market - Industry Life Cycle

3.4 United States (US) Immunology Market - Porter's Five Forces

3.5 United States (US) Immunology Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United States (US) Immunology Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.7 United States (US) Immunology Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Immunology Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Immunology Market Trends

6 United States (US) Immunology Market, By Types

6.1 United States (US) Immunology Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United States (US) Immunology Market Revenues & Volume, By Drug Class, 2021 - 2031F

6.1.3 United States (US) Immunology Market Revenues & Volume, By Monoclonal Antibody (mAb), 2021 - 2031F

6.1.4 United States (US) Immunology Market Revenues & Volume, By Fusion Proteins, 2021 - 2031F

6.1.5 United States (US) Immunology Market Revenues & Volume, By Immunosuppressants, 2021 - 2031F

6.1.6 United States (US) Immunology Market Revenues & Volume, By Polyclonal Antibody (pAb), 2021 - 2031F

6.1.7 United States (US) Immunology Market Revenues & Volume, By Others, 2021 - 2031F

6.2 United States (US) Immunology Market, By Disease Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Immunology Market Revenues & Volume, By Rheumatoid Arthritis, 2021 - 2031F

6.2.3 United States (US) Immunology Market Revenues & Volume, By Psoriatic Arthritis, 2021 - 2031F

6.2.4 United States (US) Immunology Market Revenues & Volume, By Plaque Psoriasis, 2021 - 2031F

6.2.5 United States (US) Immunology Market Revenues & Volume, By Ankylosing Spondylitis, 2021 - 2031F

6.2.6 United States (US) Immunology Market Revenues & Volume, By Inflammatory Bowel Disease, 2021 - 2031F

6.2.7 United States (US) Immunology Market Revenues & Volume, By Prophylaxis of Organ Rejection, 2021 - 2031F

6.3 United States (US) Immunology Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Immunology Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F

6.3.3 United States (US) Immunology Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F

6.3.4 United States (US) Immunology Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F

7 United States (US) Immunology Market Import-Export Trade Statistics

7.1 United States (US) Immunology Market Export to Major Countries

7.2 United States (US) Immunology Market Imports from Major Countries

8 United States (US) Immunology Market Key Performance Indicators

9 United States (US) Immunology Market - Opportunity Assessment

9.1 United States (US) Immunology Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United States (US) Immunology Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.3 United States (US) Immunology Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Immunology Market - Competitive Landscape

10.1 United States (US) Immunology Market Revenue Share, By Companies, 2024

10.2 United States (US) Immunology Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Related Reports

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All